BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 52001)

  • 1. Controlled trial of urokinase in myocardial infarction. A European Collaborative Study.
    Lancet; 1975 Oct; 2(7936):624-6. PubMed ID: 52001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment by urokinase of myocardial infarction and threatened infarction. Randomised study of 120 cases].
    Brochier M; Raynaud R; Planiol T; Fauchier JP; Griguer P; Archambaud D; Pellois A; Clisson M
    Arch Mal Coeur Vaiss; 1975 Jun; 68(6):563-9. PubMed ID: 810098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urokinase treatment of threatened and acute myocardial infarct].
    Babeau P; Pras P
    Ann Med Interne (Paris); 1977 Feb; 128(2):219-25. PubMed ID: 869389
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolytic therapy in myocardial infarction.
    Duckert F
    Prog Cardiovasc Dis; 1979; 21(5):342-50. PubMed ID: 154123
    [No Abstract]   [Full Text] [Related]  

  • 5. Recanalization of obstructed coronary artery by intracoronary administration of prostacyclin in patients with acute myocardial infarction.
    Uchida Y; Hanai T; Hasegawa K; Kawamura K; Oshima T
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():377-83. PubMed ID: 6221549
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coronary arteriographic findings during early hours of acute myocardial infarction: response to intracoronary injection of nitrates and urokinase (author's transl)].
    Omote S; Yasue H; Takizawa A; Nagao M; Hyon H; Nishida S; Horie M
    Kokyu To Junkan; 1982 Jun; 30(6):633-40. PubMed ID: 7051211
    [No Abstract]   [Full Text] [Related]  

  • 7. A new "wonder" drug to dissolve clots. The results of urokinase therapy in acute myocardial infarction, pulmonary embolism and deep vein thrombosis.
    Mazel MS; Riera R; Levine ER
    Med Trial Tech Q; 1975; 22(1):52-67. PubMed ID: 1165704
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effects of coronary thrombolysis on the short- and long-term mortality in acute myocardial infarction].
    Ishikawa K; Kanamasa K; Ohno M; Morishita M; Ogawa I; Shimizu M; Hayashi T; Sakaguchi Y; Yamashita K; Kamata N
    J Cardiol; 1989 Mar; 19(1):97-101. PubMed ID: 2810055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction. Urochinasi per via Sistemica nell'Infarto Miocardico (USIM) Collaborative Group.
    Rossi P; Bolognese L
    Am J Cardiol; 1991 Sep; 68(6):585-92. PubMed ID: 1877476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemorheological factors in the management of myocardial infarct--use of urokinase].
    Kiso T; Harada H; Kawasaki T; Kishima N; Sano I; Fukuda I; Seki I; Mozai T
    Nihon Rinsho; 1979; 37(2):430-40. PubMed ID: 439432
    [No Abstract]   [Full Text] [Related]  

  • 11. Report on the use of urokinase in acute myocardial infarction.
    Mazel MS
    Vasc Surg; 1976; 10(1):46-52. PubMed ID: 961035
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of patency of infarct-related coronary artery on acute outcome in acute myocardial infarction patients undergoing urokinase therapy. Collaborative Research Group on Thrombolysis.
    Chin Med J (Engl); 1997 Mar; 110(3):187-90. PubMed ID: 9594337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinolytic treatment of myocardial infarct or acute coronary insufficiency].
    Cousteau JP
    Sem Hop Ther; 1976 Apr; 52(4):239-41. PubMed ID: 948766
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of different start time of urokinase therapy after acute myocardial infarction efficacy of thrombolysis. The Collaborative Research Group on Thrombolysis.
    Chin Med J (Engl); 1997 Jan; 110(1):47-9. PubMed ID: 9594321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of urokinase in acute myocardial infarction.
    Makolkin VI; Bokarew IN; Buturow VN; Terechow VN; Kuznetzow VA; Seryogina MV; Yarowaya LD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):394-7. PubMed ID: 2465237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombolytic treatment with urokinase (author's transl)].
    Tilsner V; Greul W
    MMW Munch Med Wochenschr; 1975 May; 117(20):865-8. PubMed ID: 124400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a thrombolytic agent (urokinase) on necrosis after acute myocardial infarction.
    Hermens WT; Witteveen SA; Hollaar L; Hemker HC
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():319-29. PubMed ID: 1208986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter clinical trial of thrombolytic therapy in 1,406 patients with acute myocardial infarction. Collaborative Group of Clinical Trial for Urokinase Therapy.
    Hu D; Xu Z
    Chin Med J (Engl); 1997 Nov; 110(11):839-42. PubMed ID: 9772414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proceedings: Ischemic heart disease and plasma fibrinolytic activity. (4). Fibrinolytic enzyme therapy in acute myocardial infarct].
    Sasa H; Mizuguchi K; Futenma S; Nakamura S; Ito K
    Jpn Circ J; 1975 Jul; 39(7):887. PubMed ID: 1160115
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of urokinase in acute myocardial infarction: report of two cases.
    Mazel MS; Parsa F; Riera R
    J Am Geriatr Soc; 1975 Sep; 23(9):419-25. PubMed ID: 1151039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.